ES diagnosis is confirmed by an in situ hybridisation test based on the EWSR1 gene break-apart probes (EWS-FLI1, t(11;22)) with histological features of small round cells and anti-CD99 antibody cytoplasmic labelling [29]. This evidence concerns the gene CD99 and Ewing sarcoma.